Company: BIOGEN INC.

Form Type: 8-K

Filing Date: 2024-03-25

Corporate Action: Spin-off

Type: New

Accession Number: 000119312524075932

Comments: The document discusses the spin-off of Biogen Inc.'s hematology division, which became Bioverativ Inc.

Document Link: View Document